FIRST DETECTION OF CLINICAL DISEASE DUE TO ELEPHANT ENDOTHELIOTROPIC HERPESVIRUS 7A IN TWO AFRICAN ELEPHANTS (LOXODONTA AFRICANA) IN HUMAN CARE

J Zoo Wildl Med. 2024 Mar;55(1):290-294. doi: 10.1638/2023-0034.

Abstract

Multiple species of elephant endotheliotropic herpesvirus (EEHV) have caused fatal hemorrhagic disease in African (Loxodonta africana) and Asian (Elephas maximus) elephants. To date, EEHV7 has been detected only in benign pulmonary and skin nodules and in saliva of African elephants and has not been associated with clinical illness. Low-level viremia due to EEHV7A was detected via qPCR in two subadult African elephants during routine surveillance. Hematologic changes were noted in both elephants, including leukopenia, lymphopenia, monocytopenia, and band heterophilia. Treatment was initiated with famciclovir, antimicrobials, and rectal fluids, and one elephant received plasma transfusions due to a progressive decrease in platelet count. Both elephants remained asymptomatic throughout the viremias, with rapid resolution of hematologic abnormalities. These cases add to the current understanding of the epidemiology of EEHV in African elephants; to the authors' knowledge, they represent the first documentation of clinical disease due to EEHV7 infection in any elephant.

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • Elephants*
  • Famciclovir / therapeutic use
  • Herpesviridae Infections* / diagnosis
  • Herpesviridae Infections* / epidemiology
  • Herpesviridae Infections* / veterinary
  • Herpesviridae*
  • Humans
  • Viremia / veterinary

Substances

  • Famciclovir
  • Antiviral Agents